EI
Exelixis Inc
🇺🇸XNAS.EXELUnited StatesHealthcare
$56.22USDup +0.01 (+0.02%)OpenEnd of day6:02 PM
Price$56.22+0.01 (+0.02%)
Profile
- Healthcare
- Biotechnology
- United States
Identity
- Exchange
- Nasdaq . XNAS
- Type
- Stock
- ISIN
- US30161Q1040
- CUSIP
- 30161Q104
Company
- Employees
- 1,077
- Headquarters
- Alameda, United States
- Website
- https://www.exelixis.com
- CEO
- Dr. Michael M. Morrissey Ph.D.
Market
- Shares outstanding
- 247.8M
- Market cap
- $13.93B
Key dates
- Next earnings
- Nov 3, 2026
Highlights
- Market cap
- $13.93B
- EPS LTM
- $3.47calculatedCalculated by Finzer, not reported by the data provider.
- P/E LTM
- 16.19calculatedCalculated by Finzer, not reported by the data provider.
- Div yield
- Not reported
Fundamentals (LTM)
- Revenue
- $2.44B+9.23%up year on year
- Net income
- $860.62M+42.89%up year on year
- Gross margin
- 96.48%-0.12%down year on year
- Free cash flow
- $1.18B+63.36%up year on year
Other listings
These are the venues Finzer covers, not every venue that exists.
Business summary
No company summary reported yet.